z-logo
open-access-imgOpen Access
Molecular Epidemiology of Community‐AcquiredStaphylococcus aureusin Families with and without Cystic Fibrosis Patients
Author(s) -
Christiane Goerke,
Kerstin Kraning,
Martin Stern,
Gerd Döring,
K Botzenhart,
Christiane Wolz
Publication year - 2000
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/315331
Subject(s) - staphylococcus aureus , molecular epidemiology , epidemiology , cystic fibrosis , microbiology and biotechnology , pulsed field gel electrophoresis , biology , transmission (telecommunications) , antibiotics , micrococcaceae , staphylococcal infections , genotype , medicine , bacteria , genetics , gene , electrical engineering , engineering
The molecular epidemiology of Staphylococcus aureus nasal commensal strains and community-acquired infecting strains was assessed by comparison of prevalence, persistence, transmission rate, and clonal distribution of S. aureus in families with and without cystic fibrosis (CF) patients. Isolates were typed by pulsed-field gel electrophoresis. CF patients without antibiotic treatment had a significantly higher nasal prevalence (66%) of S. aureus than did treated patients (29%; P<.001) or healthy controls (32%; P<.001), suggesting that persons with CF have a higher susceptibility to this organism. Strain transmission was frequent within both CF (55%) and non-CF (62%) families. After 3 and 19 months, 57% and 21%, respectively, of all persons still harbored the same S. aureus strain. Most of the isolates (78%) belonged to 8 of 38 genome types common in CF patients and in healthy persons. The predominant occurrence of a limited number of S. aureus clones within the community suggests evolutionary mechanisms for the selection of certain strains without an obvious association with disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom